| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoacylglycerol lipase activity | 1.63e-05 | 16 | 63 | 3 | GO:0047372 | |
| GeneOntologyMolecularFunction | MAP kinase activity | 1.63e-05 | 16 | 63 | 3 | GO:0004707 | |
| GeneOntologyMolecularFunction | keratan sulfotransferase activity | 5.85e-05 | 4 | 63 | 2 | GO:0045130 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 8.77e-05 | 74 | 63 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine 6-O-sulfotransferase activity | 2.04e-04 | 7 | 63 | 2 | GO:0001517 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 6.99e-04 | 55 | 63 | 3 | GO:0008146 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ELOVL4 CHRNA6 IL13RA1 TAS2R7 NRXN3 PKD1 HRH1 LRP5 OR11H12 PTCH1 GNRHR PTK7 | 9.43e-04 | 1353 | 63 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | glucosidase activity | 1.00e-03 | 15 | 63 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.29e-03 | 17 | 63 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | magnesium ion transmembrane transporter activity | 1.45e-03 | 18 | 63 | 2 | GO:0015095 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 3.17e-05 | 121 | 62 | 5 | GO:0030203 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 4.81e-05 | 132 | 62 | 5 | GO:0006022 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 8.07e-05 | 76 | 62 | 4 | GO:0006024 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 9.86e-05 | 80 | 62 | 4 | GO:0006023 | |
| GeneOntologyBiologicalProcess | acylglycerol metabolic process | 1.06e-04 | 156 | 62 | 5 | GO:0006639 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 1.09e-04 | 365 | 62 | 7 | GO:0006790 | |
| GeneOntologyBiologicalProcess | neutral lipid metabolic process | 1.13e-04 | 158 | 62 | 5 | GO:0006638 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 1.26e-04 | 646 | 62 | 9 | GO:0005975 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.31e-04 | 376 | 62 | 7 | GO:0008202 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | DAGLB PIGY ELOVL4 MOGAT1 MBOAT7 TSPO TM7SF2 HRH1 ABHD1 CERS4 | 1.44e-04 | 813 | 62 | 10 | GO:0008610 |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 1.97e-04 | 178 | 62 | 5 | GO:0044272 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 2.34e-04 | 100 | 62 | 4 | GO:1903510 | |
| GeneOntologyBiologicalProcess | glycoside catabolic process | 3.16e-04 | 9 | 62 | 2 | GO:0016139 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PIGY ELOVL4 LMF1 MOGAT1 ABHD12B MBOAT7 TMEM94 TM7SF2 ALG3 EXT2 GBA2 GRAMD4 CERS4 | 1.05e-04 | 1293 | 63 | 13 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PIGY ELOVL4 LMF1 MOGAT1 ABHD12B MBOAT7 TMEM94 TM7SF2 ALG3 EXT2 GBA2 GRAMD4 CERS4 | 1.10e-04 | 1299 | 63 | 13 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PIGY ELOVL4 LMF1 MOGAT1 ABHD12B MBOAT7 TMEM94 TM7SF2 ALG3 EXT2 GBA2 GRAMD4 CERS4 | 1.36e-04 | 1327 | 63 | 13 | GO:0042175 |
| Domain | MAPK_p38 | 1.39e-07 | 4 | 62 | 3 | IPR008352 | |
| Domain | MAP_kinase_CS | 7.50e-06 | 12 | 62 | 3 | IPR003527 | |
| Domain | MAPK | 7.50e-06 | 12 | 62 | 3 | PS01351 | |
| Domain | Abhydrolase_1 | 1.47e-04 | 31 | 62 | 3 | PF00561 | |
| Domain | AB_hydrolase_1 | 1.77e-04 | 33 | 62 | 3 | IPR000073 | |
| Domain | Carbohydrate_sulfotransferase | 2.25e-04 | 7 | 62 | 2 | IPR016469 | |
| Domain | Sulfotransferase_dom | 2.30e-04 | 36 | 62 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 2.30e-04 | 36 | 62 | 3 | PF00685 | |
| Domain | - | 6.57e-04 | 119 | 62 | 4 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 6.57e-04 | 119 | 62 | 4 | IPR029058 | |
| Domain | TRYPSIN_SER | 5.27e-03 | 106 | 62 | 3 | PS00135 | |
| Domain | TRYPSIN_HIS | 5.41e-03 | 107 | 62 | 3 | PS00134 | |
| Domain | Peptidase_S1A | 6.29e-03 | 113 | 62 | 3 | IPR001314 | |
| Domain | TRYPSIN_DOM | 6.61e-03 | 115 | 62 | 3 | PS50240 | |
| Domain | Tryp_SPc | 6.93e-03 | 117 | 62 | 3 | SM00020 | |
| Domain | Trypsin | 7.60e-03 | 121 | 62 | 3 | PF00089 | |
| Domain | Trypsin_dom | 7.60e-03 | 121 | 62 | 3 | IPR001254 | |
| Domain | Peptidase_S1_PA | 7.95e-03 | 123 | 62 | 3 | IPR009003 | |
| Domain | EGF | 8.49e-03 | 126 | 62 | 3 | PF00008 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 8.33e-07 | 6 | 50 | 3 | M47766 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 3.12e-06 | 29 | 50 | 4 | M39676 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 1.17e-05 | 13 | 50 | 3 | M1441 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.12e-05 | 161 | 50 | 6 | M39770 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 2.23e-05 | 47 | 50 | 4 | M39518 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 4.59e-05 | 20 | 50 | 3 | M12256 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 5.92e-05 | 118 | 50 | 5 | M39852 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS | 6.17e-05 | 22 | 50 | 3 | M39902 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING | 7.07e-05 | 23 | 50 | 3 | M39709 | |
| Pathway | WP_LDL_INFLUENCE_ON_CD14_AND_TLR4 | 7.07e-05 | 23 | 50 | 3 | M45556 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 7.21e-05 | 123 | 50 | 5 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 8.09e-05 | 126 | 50 | 5 | M695 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.03e-04 | 26 | 50 | 3 | M47565 | |
| Pathway | WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION | 1.16e-04 | 27 | 50 | 3 | M39838 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 1.29e-04 | 28 | 50 | 3 | M39572 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.49e-04 | 76 | 50 | 4 | MM1433 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.91e-04 | 81 | 50 | 4 | M13863 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 2.13e-04 | 33 | 50 | 3 | M47550 | |
| Pathway | REACTOME_NOD1_2_SIGNALING_PATHWAY | 2.13e-04 | 33 | 50 | 3 | MM14663 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 2.33e-04 | 34 | 50 | 3 | M13881 | |
| Pathway | SIG_CD40PATHWAYMAP | 2.33e-04 | 34 | 50 | 3 | M12705 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.42e-04 | 250 | 50 | 6 | M27554 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 2.56e-04 | 7 | 50 | 2 | MM14672 | |
| Pathway | REACTOME_NOD1_2_SIGNALING_PATHWAY | 2.76e-04 | 36 | 50 | 3 | M1059 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 2.76e-04 | 36 | 50 | 3 | M39908 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 4.44e-04 | 101 | 50 | 4 | M1979 | |
| Pathway | REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION | 5.45e-04 | 10 | 50 | 2 | M27146 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 5.45e-04 | 10 | 50 | 2 | MM15135 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 5.45e-04 | 10 | 50 | 2 | M13962 | |
| Pathway | WP_THERMOGENESIS | 5.72e-04 | 108 | 50 | 4 | M39746 | |
| Pathway | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | 6.10e-04 | 47 | 50 | 3 | MM14664 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING | 7.76e-04 | 51 | 50 | 3 | M39438 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 7.95e-04 | 12 | 50 | 2 | MM14657 | |
| Pathway | KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS | 8.68e-04 | 53 | 50 | 3 | M3812 | |
| Pathway | WP_IL4_SIGNALING | 9.17e-04 | 54 | 50 | 3 | M39720 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 9.17e-04 | 54 | 50 | 3 | MM14633 | |
| Pathway | WP_HYPOXIADEPENDENT_DIFFERENTIATION_OF_MYOBLASTS | 9.38e-04 | 13 | 50 | 2 | MM15894 | |
| Pathway | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | 1.02e-03 | 56 | 50 | 3 | M1074 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.07e-03 | 57 | 50 | 3 | M692 | |
| Pathway | WP_PARKINSONS_DISEASE | 1.07e-03 | 57 | 50 | 3 | MM15899 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 1.21e-03 | 132 | 50 | 4 | M39338 | |
| Pathway | WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY | 1.25e-03 | 60 | 50 | 3 | M39583 | |
| Pathway | KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.37e-03 | 62 | 50 | 3 | M15569 | |
| Pathway | REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA | 1.62e-03 | 17 | 50 | 2 | M959 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.63e-03 | 143 | 50 | 4 | M27275 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.79e-03 | 68 | 50 | 3 | M39456 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 1.79e-03 | 68 | 50 | 3 | M16848 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.03e-03 | 71 | 50 | 3 | M15913 | |
| Pathway | WP_PARKINSONS_DISEASE_PATHWAY | 2.03e-03 | 71 | 50 | 3 | M39461 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 2.03e-03 | 19 | 50 | 2 | MM14780 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 2.11e-03 | 72 | 50 | 3 | M3126 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 2.37e-03 | 75 | 50 | 3 | M39568 | |
| Pathway | WP_INSULIN_SIGNALING | 2.45e-03 | 160 | 50 | 4 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 2.45e-03 | 160 | 50 | 4 | M39482 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 2.46e-03 | 76 | 50 | 3 | M1749 | |
| Pathway | PID_P38_MK2_PATHWAY | 2.48e-03 | 21 | 50 | 2 | M199 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.65e-03 | 271 | 50 | 5 | MM15406 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 2.65e-03 | 78 | 50 | 3 | M39824 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 2.72e-03 | 22 | 50 | 2 | M13408 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.72e-03 | 22 | 50 | 2 | MM1443 | |
| Pathway | PID_P73PATHWAY | 2.75e-03 | 79 | 50 | 3 | M19 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 2.75e-03 | 79 | 50 | 3 | M11816 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.97e-03 | 23 | 50 | 2 | M2821 | |
| Pathway | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | 2.97e-03 | 23 | 50 | 2 | M17243 | |
| Pathway | WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART | 3.24e-03 | 24 | 50 | 2 | M39576 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 3.24e-03 | 24 | 50 | 2 | M27553 | |
| Pathway | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | 3.24e-03 | 24 | 50 | 2 | MM15133 | |
| Pathway | REACTOME_MYOGENESIS | 3.24e-03 | 24 | 50 | 2 | MM15174 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 3.38e-03 | 85 | 50 | 3 | M3578 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.44e-03 | 288 | 50 | 5 | M16864 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 3.51e-03 | 25 | 50 | 2 | MM15269 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 3.51e-03 | 25 | 50 | 2 | M274 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.61e-03 | 87 | 50 | 3 | M27617 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 3.79e-03 | 26 | 50 | 2 | M7330 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 3.79e-03 | 26 | 50 | 2 | MM14716 | |
| Pathway | PID_P38_MKK3_6PATHWAY | 3.79e-03 | 26 | 50 | 2 | M20 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 4.09e-03 | 27 | 50 | 2 | M39863 | |
| Pathway | WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING | 4.09e-03 | 27 | 50 | 2 | M39609 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 4.09e-03 | 27 | 50 | 2 | M45550 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 4.09e-03 | 27 | 50 | 2 | MM14779 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 4.39e-03 | 28 | 50 | 2 | M670 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 4.39e-03 | 28 | 50 | 2 | MM15132 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 4.39e-03 | 28 | 50 | 2 | MM14798 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 4.71e-03 | 29 | 50 | 2 | MM14802 | |
| Pathway | REACTOME_MYOGENESIS | 4.71e-03 | 29 | 50 | 2 | M853 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 4.82e-03 | 757 | 50 | 8 | M27451 | |
| Pathway | WP_SPHINGOLIPID_PATHWAY | 5.03e-03 | 30 | 50 | 2 | M39501 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 5.03e-03 | 30 | 50 | 2 | M76 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 5.37e-03 | 31 | 50 | 2 | M685 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 5.37e-03 | 31 | 50 | 2 | M15195 | |
| Pathway | PID_CD40_PATHWAY | 5.37e-03 | 31 | 50 | 2 | M45 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.63e-03 | 102 | 50 | 3 | M3261 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3 | 5.71e-03 | 32 | 50 | 2 | M40041 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 5.79e-03 | 103 | 50 | 3 | M39434 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 5.79e-03 | 103 | 50 | 3 | MM14752 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 5.93e-03 | 620 | 50 | 7 | MM15193 | |
| Pathway | PID_NCADHERIN_PATHWAY | 6.07e-03 | 33 | 50 | 2 | M266 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 21336470 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 20610565 | ||
| Pubmed | Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis. | 2.37e-08 | 4 | 64 | 3 | 18177852 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 10066767 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 15632108 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 17304211 | ||
| Pubmed | Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice. | 1.18e-07 | 6 | 64 | 3 | 27856911 | |
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 14680475 | ||
| Pubmed | F-box Protein βTrCP1 Is a Substrate of Extracellular Signal-regulated Kinase 2. | 3.31e-07 | 8 | 64 | 3 | 34703820 | |
| Pubmed | 1.29e-06 | 12 | 64 | 3 | 12171600 | ||
| Pubmed | The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. | 1.68e-06 | 13 | 64 | 3 | 17906618 | |
| Pubmed | 2.13e-06 | 14 | 64 | 3 | 12239168 | ||
| Pubmed | PRAK, a novel protein kinase regulated by the p38 MAP kinase. | 2.66e-06 | 15 | 64 | 3 | 9628874 | |
| Pubmed | Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation. | 3.33e-06 | 2 | 64 | 2 | 29357353 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10201954 | ||
| Pubmed | Counter-regulation of T cell effector function by differentially activated p38. | 3.33e-06 | 2 | 64 | 2 | 24863062 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10727080 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11352640 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16938851 | ||
| Pubmed | Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice. | 3.33e-06 | 2 | 64 | 2 | 15561967 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17241234 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27605380 | ||
| Pubmed | p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. | 3.33e-06 | 2 | 64 | 2 | 19955483 | |
| Pubmed | The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell. | 3.33e-06 | 2 | 64 | 2 | 15824134 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20188737 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17105766 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24531379 | ||
| Pubmed | Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. | 3.33e-06 | 2 | 64 | 2 | 9295308 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19539422 | ||
| Pubmed | p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart. | 3.33e-06 | 2 | 64 | 2 | 32573492 | |
| Pubmed | Effect of p38 MAP kinases on contractility and ischemic injury in intact heart. | 3.33e-06 | 2 | 64 | 2 | 19706373 | |
| Pubmed | p38α blocks brown adipose tissue thermogenesis through p38δ inhibition. | 3.33e-06 | 2 | 64 | 2 | 29979672 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31661126 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21440637 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21865449 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 29287762 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20053787 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11017086 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 5.10e-06 | 697 | 64 | 9 | 28298427 | |
| Pubmed | 8.93e-06 | 22 | 64 | 3 | 16751104 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31780731 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31148596 | ||
| Pubmed | Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells. | 9.99e-06 | 3 | 64 | 2 | 24673557 | |
| Pubmed | Enzymatic synthesis in vitro of the disulfated disaccharide unit of corneal keratan sulfate. | 9.99e-06 | 3 | 64 | 2 | 12218059 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17210568 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 15304097 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31273206 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22522454 | ||
| Pubmed | The transcriptional activator Mirk/Dyrk1B is sequestered by p38alpha/beta MAP kinase. | 9.99e-06 | 3 | 64 | 2 | 12384504 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17965772 | ||
| Pubmed | Chemical genetics define the roles of p38alpha and p38beta in acute and chronic inflammation. | 9.99e-06 | 3 | 64 | 2 | 17855341 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 21715315 | ||
| Pubmed | Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase. | 9.99e-06 | 3 | 64 | 2 | 15273249 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18641461 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18256287 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11495898 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 26666822 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20162623 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18559936 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16364914 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11278593 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 33605979 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 9218798 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 10491328 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 23483889 | ||
| Pubmed | Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. | 2.00e-05 | 4 | 64 | 2 | 15708845 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 15143069 | ||
| Pubmed | Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. | 2.00e-05 | 4 | 64 | 2 | 10330143 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 23129748 | ||
| Pubmed | p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. | 2.00e-05 | 4 | 64 | 2 | 17139251 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 18367666 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 19936205 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 15728454 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 20188673 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 12374793 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 24161934 | ||
| Pubmed | Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. | 2.00e-05 | 4 | 64 | 2 | 28011639 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 26479921 | ||
| Pubmed | Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2. | 2.00e-05 | 4 | 64 | 2 | 23568773 | |
| Pubmed | Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins. | 2.00e-05 | 4 | 64 | 2 | 20378550 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 22935704 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 23639288 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 17074887 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 9207191 | ||
| Pubmed | A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. | 3.32e-05 | 5 | 64 | 2 | 17380123 | |
| Pubmed | p38α MAPK proximity assay reveals a regulatory mechanism of alternative splicing in cardiomyocytes. | 3.32e-05 | 5 | 64 | 2 | 31505169 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 30867513 | ||
| Pubmed | ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome. | 3.32e-05 | 5 | 64 | 2 | 35857590 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 12612065 | ||
| Pubmed | Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells. | 3.32e-05 | 5 | 64 | 2 | 28864471 | |
| Pubmed | RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. | 3.32e-05 | 5 | 64 | 2 | 9465032 | |
| Pubmed | MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation. | 3.32e-05 | 5 | 64 | 2 | 35971771 | |
| Pubmed | 3.41e-05 | 34 | 64 | 3 | 23300479 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 25113562 | ||
| Pubmed | Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases. | 4.98e-05 | 6 | 64 | 2 | 22447027 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 25754930 | ||
| Pubmed | Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. | 4.98e-05 | 6 | 64 | 2 | 15735648 | |
| Pubmed | Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice. | 4.98e-05 | 6 | 64 | 2 | 10383162 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 22231518 | ||
| Pubmed | Enzymes responsible for synthesis of corneal keratan sulfate glycosaminoglycans. | 4.98e-05 | 6 | 64 | 2 | 17690104 | |
| Cytoband | 16p13.3 | 3.85e-04 | 244 | 64 | 4 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.19e-03 | 330 | 64 | 4 | chr22q13 | |
| Cytoband | 22q13.33 | 1.30e-03 | 38 | 64 | 2 | 22q13.33 | |
| Cytoband | 22q13.31 | 1.90e-03 | 46 | 64 | 2 | 22q13.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 2.99e-03 | 426 | 64 | 4 | chr16p13 | |
| GeneFamily | Mitogen-activated protein kinases | 3.52e-06 | 13 | 43 | 3 | 651 | |
| GeneFamily | Abhydrolase domain containing | 1.87e-05 | 22 | 43 | 3 | 4 | |
| GeneFamily | Sulfotransferases, membrane bound | 9.20e-05 | 37 | 43 | 3 | 763 | |
| Coexpression | GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 8.66e-06 | 200 | 63 | 6 | M6842 | |
| CoexpressionAtlas | e10.5_Nasal_Pit_top-relative-expression-ranked_250 | 1.54e-05 | 189 | 60 | 6 | Facebase_ST1_e10.5_Nasal_Pit_250 | |
| Drug | tolyltriazole | 8.48e-10 | 6 | 64 | 4 | CID000025902 | |
| Drug | Ac2-26 | 8.46e-08 | 4 | 64 | 3 | CID000568638 | |
| Drug | NSC-68458 | 8.46e-08 | 4 | 64 | 3 | CID000249771 | |
| Drug | SD-282 | 1.01e-07 | 16 | 64 | 4 | CID014973220 | |
| Drug | tyrphostin B46 | 4.83e-07 | 23 | 64 | 4 | CID000002058 | |
| Drug | Cp-38 | 7.35e-07 | 7 | 64 | 3 | CID006918286 | |
| Drug | satratoxin H | 7.35e-07 | 7 | 64 | 3 | CID000434380 | |
| Drug | 2,2',4,6-tetrachlorobiphenyl | 7.35e-07 | 7 | 64 | 3 | CID000044163 | |
| Drug | CID6325568 | 7.35e-07 | 7 | 64 | 3 | CID006325568 | |
| Drug | Z-D-CH2DCB | 1.17e-06 | 8 | 64 | 3 | CID009911778 | |
| Drug | ML3403 | 1.17e-06 | 8 | 64 | 3 | CID006419739 | |
| Drug | SB220025 | 1.28e-06 | 29 | 64 | 4 | CID000005164 | |
| Drug | 1xp1 | 1.57e-06 | 70 | 64 | 5 | CID000449205 | |
| Drug | SC68376 | 1.76e-06 | 9 | 64 | 3 | CID000005174 | |
| Drug | AC1NOLIT | 2.51e-06 | 10 | 64 | 3 | CID005090286 | |
| Drug | nemorosone | 3.44e-06 | 11 | 64 | 3 | CID000637105 | |
| Drug | sesamolin | 4.58e-06 | 12 | 64 | 3 | CID000101746 | |
| Drug | Substance P | 5.19e-06 | 343 | 64 | 8 | CID000036511 | |
| Drug | AGEPC | 6.82e-06 | 356 | 64 | 8 | CID000461545 | |
| Drug | SB-242235 | 7.54e-06 | 14 | 64 | 3 | CID009863367 | |
| Drug | SB202474 | 7.54e-06 | 14 | 64 | 3 | CID000005162 | |
| Drug | CPI-1189 | 7.54e-06 | 14 | 64 | 3 | CID000151118 | |
| Drug | poly-N-acetyllactosamine | 7.78e-06 | 2 | 64 | 2 | ctd:C037199 | |
| Drug | adaphostin | 8.48e-06 | 46 | 64 | 4 | CID000387042 | |
| Drug | celiprolol | 9.25e-06 | 47 | 64 | 4 | CID000002663 | |
| Drug | MMP-2 Inhibitor I | 9.41e-06 | 15 | 64 | 3 | CID000004220 | |
| Drug | epicholesterol | DAGLB CHRNA6 MAPK14 SLC12A4 TSPO TM7SF2 LRP5 PTCH1 MAPK11 MAPK13 | 1.05e-05 | 636 | 64 | 10 | CID000000304 |
| Drug | benzenesulfonyl fluoride | 1.09e-05 | 49 | 64 | 4 | CID000067779 | |
| Drug | SB 239063 | 1.16e-05 | 16 | 64 | 3 | CID000005166 | |
| Drug | AMP 579 | 1.16e-05 | 16 | 64 | 3 | CID006918429 | |
| Drug | Ambotz208527-57-5 | 1.40e-05 | 17 | 64 | 3 | CID010258704 | |
| Drug | dracorhodin | 1.40e-05 | 17 | 64 | 3 | CID000069509 | |
| Drug | kazinol B | 1.40e-05 | 17 | 64 | 3 | CID000480869 | |
| Drug | SIN-1 chloride | 1.50e-05 | 53 | 64 | 4 | CID000065388 | |
| Drug | AC1L9HFF | 1.74e-05 | 55 | 64 | 4 | CID000445102 | |
| Drug | hydroxybutyrate | 1.81e-05 | 115 | 64 | 5 | CID000010413 | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; PC3; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 4502_UP | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; PC3; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 6351_DN | |
| Drug | S)-bromoenol lactone | 2.14e-05 | 119 | 64 | 5 | CID000002445 | |
| Drug | 6-((2-(4-imidazolyl)ethyl)amino)heptanoic acid 4-toluidide | 2.33e-05 | 3 | 64 | 2 | ctd:C081972 | |
| Drug | phloroglucinaldehyde | 2.33e-05 | 3 | 64 | 2 | CID000068099 | |
| Drug | virgaureasaponin | 2.33e-05 | 3 | 64 | 2 | CID006324777 | |
| Drug | N-nitroso-2-acetylaminofluorene | 2.33e-05 | 3 | 64 | 2 | CID000107997 | |
| Drug | compound 9b | 2.33e-05 | 20 | 64 | 3 | CID000207510 | |
| Drug | n-sulfo-2-aminotricarballylate | 2.33e-05 | 20 | 64 | 3 | CID000135808 | |
| Drug | aniline mustard | 2.33e-05 | 20 | 64 | 3 | CID000011108 | |
| Drug | 1-acetyl-sn-glycero-3-phosphocholine | 2.34e-05 | 305 | 64 | 7 | CID005311264 | |
| Drug | lecithin | 2.34e-05 | 305 | 64 | 7 | CID010425705 | |
| Drug | 2-ketobenzothiazole 23 | 2.46e-05 | 60 | 64 | 4 | CID003348131 | |
| Drug | Clorocruoro Hem | 2.51e-05 | 123 | 64 | 5 | CID003518809 | |
| Drug | L0168 | 2.72e-05 | 21 | 64 | 3 | CID000445856 | |
| Drug | propranolol | 2.84e-05 | 434 | 64 | 8 | CID000004946 | |
| Drug | Ro 31-8220 | 3.24e-05 | 321 | 64 | 7 | CID000005083 | |
| Drug | AC1Q5U59 | 4.04e-05 | 68 | 64 | 4 | CID000005441 | |
| Drug | SKF86002 | 4.11e-05 | 24 | 64 | 3 | CID000005228 | |
| Drug | ethyl acetate | 4.20e-05 | 137 | 64 | 5 | CID000008857 | |
| Drug | R59949 | 4.53e-05 | 70 | 64 | 4 | CID000657356 | |
| Drug | 5-hydroxy-2-nitrobenzaldehyde | 4.65e-05 | 4 | 64 | 2 | CID000039211 | |
| Drug | 4-nitroso-m-cresol | 4.65e-05 | 4 | 64 | 2 | CID000011981 | |
| Drug | 4'-O-(beta-D-glucopyranosyl)-D-pantothenic acid | 4.65e-05 | 4 | 64 | 2 | CID003082306 | |
| Drug | VX-745 | 4.66e-05 | 25 | 64 | 3 | CID003038525 | |
| Drug | GF109203X | 4.75e-05 | 341 | 64 | 7 | CID000002396 | |
| Drug | CAS 83919-23-7 | 5.26e-05 | 26 | 64 | 3 | CID000004240 | |
| Drug | AC1NSK9Q | 5.26e-05 | 26 | 64 | 3 | CID005311233 | |
| Drug | H S Q | 5.70e-05 | 351 | 64 | 7 | CID000000897 | |
| Drug | Glycan | 6.07e-05 | 148 | 64 | 5 | CID000000871 | |
| Drug | AC1L1DDL | 7.28e-05 | 79 | 64 | 4 | CID000002304 | |
| Drug | methylazoxymethyl-beta-D-glucosiduronic acid | 7.74e-05 | 5 | 64 | 2 | CID000149476 | |
| Drug | Keratan Sulfate | 7.74e-05 | 5 | 64 | 2 | ctd:D007632 | |
| Drug | AC1L8VCN | 7.74e-05 | 5 | 64 | 2 | CID000408702 | |
| Drug | AC1Q5THZ | 7.91e-05 | 502 | 64 | 8 | CID000001959 | |
| Drug | L001226 | 8.15e-05 | 30 | 64 | 3 | CID004373102 | |
| Drug | CGP57380 | 9.00e-05 | 31 | 64 | 3 | CID011644425 | |
| Drug | 4-ethylphenol | 9.00e-05 | 31 | 64 | 3 | CID000031242 | |
| Drug | valproate | 9.51e-05 | 381 | 64 | 7 | CID000003121 | |
| Drug | halofuginone lactate | 9.69e-05 | 85 | 64 | 4 | CID000062891 | |
| Drug | K00039 | 9.91e-05 | 32 | 64 | 3 | CID009549277 | |
| Drug | malolactomycin D | 9.91e-05 | 32 | 64 | 3 | CID006449115 | |
| Drug | lapatinib | 1.01e-04 | 86 | 64 | 4 | CID000208908 | |
| Drug | AC1L1GZB | 1.07e-04 | 167 | 64 | 5 | CID000003908 | |
| Drug | 7-OHIQ | 1.16e-04 | 6 | 64 | 2 | CID000115222 | |
| Drug | 4'-O-(beta-D-glucopyranosyl)-D-hopantenic acid | 1.16e-04 | 6 | 64 | 2 | CID000129183 | |
| Drug | X1207 | 1.16e-04 | 6 | 64 | 2 | CID000084718 | |
| Drug | AMPK inhibitor | 1.16e-04 | 89 | 64 | 4 | CID011524144 | |
| Drug | temazepam | 1.19e-04 | 34 | 64 | 3 | CID000005391 | |
| Drug | AC1NSKHR | 1.19e-04 | 34 | 64 | 3 | CID005311362 | |
| Drug | Leupeptin hydrochloride | 1.25e-04 | 276 | 64 | 6 | CID000003910 | |
| Drug | AC1L1KQK | 1.42e-04 | 36 | 64 | 3 | CID000005612 | |
| Drug | pyridinyl imidazole | 1.42e-04 | 36 | 64 | 3 | CID000005171 | |
| Drug | 1kkq | 1.42e-04 | 36 | 64 | 3 | CID000446738 | |
| Drug | Caffeic Acid-13C3 | 1.49e-04 | 95 | 64 | 4 | CID000002518 | |
| Drug | NSC342435 | 1.54e-04 | 37 | 64 | 3 | CID000334935 | |
| Drug | chloroquine | 1.58e-04 | 288 | 64 | 6 | CID000002719 | |
| Drug | cGpGp | 1.67e-04 | 38 | 64 | 3 | CID000124875 | |
| Drug | MnTMPyP | 1.80e-04 | 39 | 64 | 3 | CID000004233 | |
| Drug | biochanin A | 1.89e-04 | 101 | 64 | 4 | CID005280373 | |
| Drug | KT5720 | 1.92e-04 | 189 | 64 | 5 | CID000003844 | |
| Drug | lipoic acid | 1.92e-04 | 189 | 64 | 5 | CID000000864 | |
| Drug | Go6983 | 1.94e-04 | 40 | 64 | 3 | CID000003499 | |
| Drug | procymidone | 1.94e-04 | 40 | 64 | 3 | CID000036242 | |
| Disease | microphthalmia (is_implicated_in) | 2.60e-05 | 4 | 62 | 2 | DOID:10629 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 2.60e-05 | 4 | 62 | 2 | DOID:898 (is_implicated_in) | |
| Disease | colipase measurement | 6.48e-05 | 6 | 62 | 2 | EFO_0801485 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 9.06e-05 | 7 | 62 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | electrodermal activity measurement, skin conductance response amplitude | 9.06e-05 | 7 | 62 | 2 | EFO_0006866, EFO_0006868 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 9.06e-05 | 7 | 62 | 2 | EFO_0800551 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.89e-04 | 14 | 62 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Schizoaffective disorder-bipolar type | 5.11e-04 | 16 | 62 | 2 | EFO_0009965 | |
| Disease | visual perception measurement | 1.26e-03 | 223 | 62 | 4 | EFO_0009700 | |
| Disease | blood rubidium measurement | 1.37e-03 | 26 | 62 | 2 | EFO_0021529 | |
| Disease | ocular sarcoidosis | 1.89e-03 | 116 | 62 | 3 | EFO_0010723 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WLHKGWQPCMYISFL | 156 | Q9NYP8 | |
| LSVLYHESWLWAPVM | 151 | Q9HA82 | |
| PLGWRSLWIGYSFLM | 1591 | Q14031 | |
| MENWTGRPWLYLLLL | 1 | Q6UY14 | |
| YWWLRMQIMTHLPGA | 321 | Q02338 | |
| HGAWPWMVSLQIFTY | 51 | P10323 | |
| HTLPYLLWAMPARWL | 366 | Q92685 | |
| YMNAVWHGWAIPLFL | 241 | Q6IC98 | |
| WWDMVDRNLRYFPHS | 26 | Q7Z5M8 | |
| MLAARHYWNAWLPLL | 1031 | Q8IYW2 | |
| WMGYELPFDRHDWII | 201 | P53701 | |
| LWAPYRPVVWHGMAM | 3846 | Q96M86 | |
| RWGMWYKHQPLDLIR | 371 | Q9BYT9 | |
| MWLYFDWHTPERGGR | 56 | Q96PD6 | |
| RWYRAPEIMLNWMHY | 186 | Q15759 | |
| LYIPMYWWHHIESLL | 271 | Q9NWT6 | |
| CPFPKWMHWALIAYA | 241 | Q9GZR5 | |
| MLLLHGFPEFWYSWR | 96 | Q8IUS5 | |
| RWYRAPEIMLNWMHY | 186 | Q16539 | |
| IALDPAHGYMYWTDW | 156 | O75197 | |
| MGLPNQWARYLRWDA | 31 | Q9Y4C0 | |
| RWYRAPEVILSWMHY | 186 | O15264 | |
| AWTMLLSAYWHGLHP | 346 | Q96N66 | |
| WHNLSYMKCSWLPGR | 136 | P78552 | |
| GWWGMVRHPNYLGDL | 341 | O76062 | |
| LRHIWNDYKLRWDPM | 86 | Q15825 | |
| VSNHWWYSMLILPPL | 196 | Q8NB78 | |
| LGIWYWFDPEMLNRL | 286 | P30968 | |
| GMGLRYLQWWYRKTH | 116 | Q9HCG7 | |
| LWWIGILTLYLMHRG | 31 | Q8NCG7 | |
| SLWWPYLMHERPAYL | 286 | P08236 | |
| TYWVHWHMLEILGPE | 426 | Q8IWT3 | |
| FLWVIPILGWNHFMQ | 156 | P35367 | |
| NLWWPYLMHEHPASL | 61 | Q15486 | |
| RWPGVYLLQWQMHSP | 606 | O43304 | |
| RMSWPHGALLFLWLF | 16 | Q9NT99 | |
| EELWPWMAHVLLPYV | 3721 | P98161 | |
| AFVLWCDWRLHTPMY | 61 | B2RN74 | |
| PRWHLMGLVSWSYDK | 681 | Q6UXH9 | |
| GWYLSQMPFSWPHQL | 101 | O14792 | |
| GWRHWLEGEMLYLEL | 106 | P82980 | |
| WQVSLRVRGPYWMHF | 51 | Q9BZJ3 | |
| PFFRHMNWDDLLAWR | 326 | Q9UBS0 | |
| QRLTFKLCHMYWNWP | 921 | Q8TC59 | |
| VWWYLLMRLGPHLPA | 341 | Q5UIP0 | |
| PKMWLHYFRDWLQGL | 841 | Q13635 | |
| PYEHSYMWWLSIGAL | 51 | Q6UWV7 | |
| SWAGMLLDYFQHWPV | 81 | Q96GZ6 | |
| AMPAYWNLGFQLSRW | 346 | P14410 | |
| MRHNSVVLGWPYGWR | 786 | Q9UP95 | |
| FLEGLLPWQHWYMSR | 361 | Q96SE0 | |
| LPWQHWYMSRLLHQY | 366 | Q96SE0 | |
| PDVFYLMEPAWHVWT | 86 | Q9GZS9 | |
| VFYLMEPAWHVWTTL | 66 | Q9GZX3 | |
| IGNFFHPLFLWMKWR | 111 | Q9NYW3 | |
| PWLMVSAAHRLYWPH | 281 | Q6ZTK2 | |
| HMPFAPSWSLHWAYR | 156 | Q12767 | |
| YPGRLHLWDHEMNKW | 566 | Q93063 | |
| IPVYVFFHLWTWMGI | 51 | Q3MUY2 | |
| WNEMLAYHRKPITHW | 481 | Q6XYQ8 | |
| MITGPWRSLWIRFGY | 291 | Q9Y5Q8 | |
| GEHLGSFYAPRVWWM | 101 | Q16762 | |
| WVWEQEPLLRMSRHY | 511 | P52888 | |
| YHFRQAWVPLRWMSP | 961 | Q13308 | |
| HWVLGPVWGTLYSAM | 46 | P30536 | |
| SHGMKLERYIWDDPW | 156 | Q8WXB4 | |
| SPYHYRLDWLMWFAA | 456 | Q96S06 |